Benign neoplasm of other and unspecified sites

CD2_BENIGN_OTHER_NOS

benign neoplasm: A neoplasm which is characterized by the absence of morphologic features associated with malignancy (severe cytologic atypia, tumor cell necrosis, and high mitotic rate). Benign neoplasms remain confined to the original site of growth and do not metastasize to other anatomic sites.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D36
Cause of death: ICD-10 D36

519

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10 ; C.O.D: 10

519

diagram downward connector

Check minimum number of events None

519

diagram downward connector
CD2_BENIGN_OTHER_NOS

Extra metadata

Level in the ICD hierarchy 2
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D10-D36
Name in latin Neoplasmata benigna locis aliis et non specificatis

Summary Statistics

Key figures

All Female Male
Number of individuals 685 395 290
Unadjusted prevalence (%) 0.22 0.23 0.21
Mean age at first event (years) 47.90 46.49 49.83

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 3.23 [1.88, 5.57] 2.4e-5 66
15 years 0.01 1.41 [0.77, 2.57] 2.7e-1 25
5 years 0.00 2.74 [1.47, 5.12] 1.6e-3 16
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CD2_BENIGN_OTHER_NOS – Benign neoplasm of other and unspecified sites
GWS hits: 0

Survival analyses between endpoints

Plot

before Benign neoplasm of other and unspecified sites
after Benign neoplasm of other and unspecified sites

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Benign neoplasm of other and unspecified sites